BioCardia (BCDA) Non Operating Interest Expenses (2016 - 2020)

BioCardia (BCDA) has reported Non Operating Interest Expenses for 4 consecutive years, with $1000.0 the latest figure, recorded in Q4 2020.

• On a quarterly basis, Non Operating Interest Expenses changed N/A year-over-year to $1000.0 in Q4 2020; TTM through Dec 2020 was $114000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $3000.0, down 97.32% from the prior year.
• Non Operating Interest Expenses was $1000.0 for Q4 2020 at BioCardia, roughly flat from $1000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $557000.0 in Q2 2016 and troughed at $1000.0 in Q1 2017.
• A 4-year average of $231375.0 and a median of $110500.0 in 2016 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses plunged 99.82% in 2017 and plunged 99.11% in 2020, its largest moves.
• Over 4 years, Non Operating Interest Expenses stood at $109000.0 in 2016, then slumped by 99.08% to $1000.0 in 2017, then surged by 11100.0% to $112000.0 in 2019, then sank by 99.11% to $1000.0 in 2020.
• The last three Non Operating Interest Expenses figures came in at $1000.0 (Q4 2020), $1000.0 (Q3 2020), and $112000.0 (Q3 2019), per Business Quant data.